PharmaShots | Incisive News in 3 Shots

Subscribe Now

Novavax

Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US

Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US

September 2, 2024

Novavax’s Nuvaxovid Receives EC’s Marketing Authorization for the Prevention of COVID-19

Novavax’s Nuvaxovid Receives EC’s Marketing Authorization for the Prevention of COVID-19

July 7, 2023

PharmaShots Weekly Snapshots (January 02 - 06, 2023)

PharmaShots Weekly Snapshots (January 02 - 06, 2023)

January 6, 2023

Novavax Initiates P-II Trial of COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

Novavax Initiates P-II Trial of COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

January 2, 2023

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

November 21, 2022

Novavax’s Nuvaxovid (NVX-CoV2373) Booster Dose Receives the MHRA Recommendation for Expanded Conditional Marketing Authorization to Prevent COVID-19

Novavax’s Nuvaxovid (NVX-CoV2373) Booster Dose Receives the MHRA Recommendation for Expanded Conditional Marketing Authorization t...

November 10, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us